BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24518602)

  • 1. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.
    Gooden MJ; Wiersma VR; Boerma A; Leffers N; Boezen HM; ten Hoor KA; Hollema H; Walenkamp AM; Daemen T; Nijman HW; Bremer E
    Br J Cancer; 2014 Mar; 110(6):1535-44. PubMed ID: 24518602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
    Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
    Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.
    Mir H; Singh R; Kloecker GH; Lillard JW; Singh S
    Oncotarget; 2015 Apr; 6(12):9985-98. PubMed ID: 25888629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
    Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
    Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.
    Gough PJ; Garton KJ; Wille PT; Rychlewski M; Dempsey PJ; Raines EW
    J Immunol; 2004 Mar; 172(6):3678-85. PubMed ID: 15004171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CXCL16 promotes TNF-α-induced apoptosis in DLBCL via the AMAD10-NF-κB regulatory feedback loop.
    Yang H; Qiu B; Chen S; Xun Y; Pan Y; Chen M; Li WX; Liao W; El-Ashram S; Yang A; Liu F
    Cell Biol Int; 2019 Aug; 43(8):863-874. PubMed ID: 31033093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
    Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
    Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L; Cui ZM; Zhang J; Huang Y
    Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints.
    van der Voort R; van Lieshout AW; Toonen LW; Slöetjes AW; van den Berg WB; Figdor CG; Radstake TR; Adema GJ
    Arthritis Rheum; 2005 May; 52(5):1381-91. PubMed ID: 15880344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.
    Gutwein P; Abdel-Bakky MS; Schramme A; Doberstein K; Kämpfer-Kolb N; Amann K; Hauser IA; Obermüller N; Bartel C; Abdel-Aziz AA; El Sayed el SM; Pfeilschifter J
    Am J Pathol; 2009 Jun; 174(6):2061-72. PubMed ID: 19435795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.
    Scholz F; Schulte A; Adamski F; Hundhausen C; Mittag J; Schwarz A; Kruse ML; Proksch E; Ludwig A
    J Invest Dermatol; 2007 Jun; 127(6):1444-55. PubMed ID: 17363916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
    Hald SM; Kiselev Y; Al-Saad S; Richardsen E; Johannessen C; Eilertsen M; Kilvaer TK; Al-Shibli K; Andersen S; Busund LT; Bremnes RM; Donnem T
    BMC Cancer; 2015 May; 15():441. PubMed ID: 26021984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
    Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
    Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways.
    Han J; Fu R; Chen C; Cheng X; Guo T; Huangfu L; Li X; Du H; Xing X; Ji J
    Int J Biol Sci; 2021; 17(11):2841-2852. PubMed ID: 34345211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.
    Abel S; Hundhausen C; Mentlein R; Schulte A; Berkhout TA; Broadway N; Hartmann D; Sedlacek R; Dietrich S; Muetze B; Schuster B; Kallen KJ; Saftig P; Rose-John S; Ludwig A
    J Immunol; 2004 May; 172(10):6362-72. PubMed ID: 15128827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
    Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
    Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
    [No Abstract]   [Full Text] [Related]  

  • 17. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
    Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
    PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet SR-PSOX/CXCL16-CXCR6 Axis Influences Thrombotic Propensity and Prognosis in Coronary Artery Disease.
    Guan T; Emschermann F; Schories C; Groga-Bada P; Martus P; Borst O; Gawaz M; Geisler T; Rath D; Chatterjee M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
    Lv Y; Hou X; Ti Y; Bu P
    Clin Nutr; 2013 Oct; 32(5):849-54. PubMed ID: 23398954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells.
    Schramme A; Abdel-Bakky MS; Kämpfer-Kolb N; Pfeilschifter J; Gutwein P
    Biochem Biophys Res Commun; 2008 May; 370(2):311-6. PubMed ID: 18373975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.